Galt stock news today

Breaking News: GALT latest news. - The Fly The Fly team scours all sources of company news, from mainstream to cutting edge,then filters out the noise to deliver shortform stories consisting of only market moving content. Breaking News: GALT latest news.

Galectin Therapeutics - GALT - Stock Price & News | The ... Real time Galectin Therapeutics (GALT) stock price time Galectin Therapeutics (GALT) stock price quote, stock graph, news & analysis. drug candidate sent its shares higher today. GALT Stock Quote - Galectin Therapeutics, Inc. Stock Price ... GALT stock quote, chart and news. Get Galectin Therapeutics, Inc.'s stock price today. Why Galectin Therapeutics Stock Bolted Higher Today | The ...

Find the latest Galectin Therapeutics Inc. (GALT) stock quote, history, news and other vital information to help you with your stock trading and investing.

GALT Stock Price | Galectin Therapeutics Inc. Stock Quote ... GALT | Complete Galectin Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Galectin Therapeutics Inc. Common Stock (GALT) News ... Find the latest news headlines from Galectin Therapeutics Inc. Common Stock (GALT) at Nasdaq.com.

Galectin Therapeutics Inc. - TheStreet

GALT stock quote, chart and news. Get Galectin Therapeutics, Inc.'s stock price today. Why Galectin Therapeutics Stock Bolted Higher Today | The ... Stock Market News; Top Stocks for 2020 Why Galectin Therapeutics Stock Bolted Higher Today GALT) are ripping higher today after the company announced a new … Galectin Therapeutics Inc. (GALT) News Headlines - NASDAQ.com Mar 05, 2020 · Galectin Therapeutics Inc. (GALT) News – Find the latest company news headlines for Galectin Therapeutics Inc. and all the companies you research at NASDAQ.com GALT -- Is Its Stock Price A Worthy Investment? Learn More. Galectin Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic disease and cancer. The company was founded in 2000 and is based in Norcross, Georgia.

Aug 24, 2019 · Galectin Therapeutics, Inc. (GALT) is working its way for to the bottom in the market in today’s trading session. The stock, focused on the biotechnology industry, is currently priced at $3.02 after tumbling -5.33% so far in today’s session.

Apr 03, 2020 · Stock quote and company snapshot for GALECTIN THERAPEUTICS INC (GALT), including profile, stock chart, recent news and events, analyst opinions, and research reports. Is the Price of GALT Stock Justified by its Earnings ... What's Happening With Galectin Therapeutics Inc. Common Stock Stock Today? Galectin Therapeutics Inc. Common Stock (GALT) stock is trading at $2.87 as of 1:57 PM on Tuesday, Feb 11, a gain of $0.33, or 13.12% from the previous closing price of $2.54. The stock has traded between $2.57 and $2.88 so far today. Volume today is above average. GALT - Galectin Therapeutics Inc Stock quote - CNNMoney.com Find real-time GALT - Galectin Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. GALT - Galectin Therapeutics Inc Stock quote - CNNMoney…

View a financial market summary for GALT including stock price quote, trading volume, volatility, options volume, statistics, and other important company data related to GALT (Galectin Therapeutics Inc.) stock.

Galectin Therapeutics Stock Price Forecast, GALT stock price prediction. What is the Galectin Therapeutics stock price / share price today? circumstances, but always read up on optimal investment strategies if you are new to investing.

Stock Market News; Top Stocks for 2020 Why Galectin Therapeutics Stock Bolted Higher Today GALT) are ripping higher today after the company announced a new … Galectin Therapeutics Inc. (GALT) News Headlines - NASDAQ.com Mar 05, 2020 · Galectin Therapeutics Inc. (GALT) News – Find the latest company news headlines for Galectin Therapeutics Inc. and all the companies you research at NASDAQ.com GALT -- Is Its Stock Price A Worthy Investment? Learn More.